nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0946	0.126	CbGbCtD
Erlotinib—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0901	0.12	CbGbCtD
Erlotinib—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0499	0.0663	CbGbCtD
Erlotinib—ALB—Prednisone—ankylosing spondylitis	0.0497	0.0659	CbGbCtD
Erlotinib—ABCG2—Dexamethasone—ankylosing spondylitis	0.045	0.0597	CbGbCtD
Erlotinib—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0429	0.0569	CbGbCtD
Erlotinib—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0415	0.0551	CbGbCtD
Erlotinib—ABCG2—Methotrexate—ankylosing spondylitis	0.0361	0.048	CbGbCtD
Erlotinib—ABCB1—Betamethasone—ankylosing spondylitis	0.0279	0.037	CbGbCtD
Erlotinib—ABCB1—Prednisolone—ankylosing spondylitis	0.0275	0.0365	CbGbCtD
Erlotinib—ABCB1—Prednisone—ankylosing spondylitis	0.026	0.0345	CbGbCtD
Erlotinib—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0257	0.0341	CbGbCtD
Erlotinib—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0249	0.0331	CbGbCtD
Erlotinib—ALB—Methotrexate—ankylosing spondylitis	0.0249	0.0331	CbGbCtD
Erlotinib—CYP2C8—Dexamethasone—ankylosing spondylitis	0.024	0.0318	CbGbCtD
Erlotinib—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0195	0.0259	CbGbCtD
Erlotinib—CYP3A4—Betamethasone—ankylosing spondylitis	0.0167	0.0222	CbGbCtD
Erlotinib—CYP3A4—Prednisolone—ankylosing spondylitis	0.0165	0.0219	CbGbCtD
Erlotinib—ABCB1—Dexamethasone—ankylosing spondylitis	0.0162	0.0215	CbGbCtD
Erlotinib—CYP3A4—Prednisone—ankylosing spondylitis	0.0156	0.0207	CbGbCtD
Erlotinib—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0153	0.0203	CbGbCtD
Erlotinib—ABCB1—Methotrexate—ankylosing spondylitis	0.013	0.0173	CbGbCtD
Erlotinib—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00971	0.0129	CbGbCtD
Erlotinib—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000499	0.00202	CcSEcCtD
Erlotinib—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000499	0.00202	CcSEcCtD
Erlotinib—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000499	0.00202	CcSEcCtD
Erlotinib—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000499	0.00202	CcSEcCtD
Erlotinib—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000495	0.002	CcSEcCtD
Erlotinib—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000495	0.002	CcSEcCtD
Erlotinib—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000494	0.002	CcSEcCtD
Erlotinib—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.00049	0.00199	CcSEcCtD
Erlotinib—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000489	0.00198	CcSEcCtD
Erlotinib—Pancreatitis—Prednisone—ankylosing spondylitis	0.000487	0.00197	CcSEcCtD
Erlotinib—Erythema—Prednisolone—ankylosing spondylitis	0.000477	0.00193	CcSEcCtD
Erlotinib—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000469	0.0019	CcSEcCtD
Erlotinib—Neutropenia—Prednisone—ankylosing spondylitis	0.000465	0.00188	CcSEcCtD
Erlotinib—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000459	0.00186	CcSEcCtD
Erlotinib—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000459	0.00186	CcSEcCtD
Erlotinib—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000457	0.00185	CcSEcCtD
Erlotinib—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000457	0.00185	CcSEcCtD
Erlotinib—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000453	0.00183	CcSEcCtD
Erlotinib—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00045	0.00182	CcSEcCtD
Erlotinib—Weight decreased—Prednisone—ankylosing spondylitis	0.00045	0.00182	CcSEcCtD
Erlotinib—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000449	0.00182	CcSEcCtD
Erlotinib—Depression—Prednisone—ankylosing spondylitis	0.000442	0.00179	CcSEcCtD
Erlotinib—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00044	0.00178	CcSEcCtD
Erlotinib—Erythema—Triamcinolone—ankylosing spondylitis	0.000438	0.00177	CcSEcCtD
Erlotinib—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000437	0.00177	CcSEcCtD
Erlotinib—Erythema—Methylprednisolone—ankylosing spondylitis	0.000437	0.00177	CcSEcCtD
Erlotinib—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000437	0.00177	CcSEcCtD
Erlotinib—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000434	0.00176	CcSEcCtD
Erlotinib—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000434	0.00176	CcSEcCtD
Erlotinib—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000433	0.00175	CcSEcCtD
Erlotinib—Syncope—Prednisolone—ankylosing spondylitis	0.000427	0.00173	CcSEcCtD
Erlotinib—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000427	0.00173	CcSEcCtD
Erlotinib—Eye disorder—Betamethasone—ankylosing spondylitis	0.000427	0.00173	CcSEcCtD
Erlotinib—Back pain—Triamcinolone—ankylosing spondylitis	0.000424	0.00172	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000419	0.0017	CcSEcCtD
Erlotinib—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000408	0.00165	CcSEcCtD
Erlotinib—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000408	0.00165	CcSEcCtD
Erlotinib—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000407	0.00165	CcSEcCtD
Erlotinib—Alopecia—Betamethasone—ankylosing spondylitis	0.000404	0.00163	CcSEcCtD
Erlotinib—Alopecia—Dexamethasone—ankylosing spondylitis	0.000404	0.00163	CcSEcCtD
Erlotinib—Haemoglobin—Prednisone—ankylosing spondylitis	0.0004	0.00162	CcSEcCtD
Erlotinib—Haemorrhage—Prednisone—ankylosing spondylitis	0.000398	0.00161	CcSEcCtD
Erlotinib—Erythema—Betamethasone—ankylosing spondylitis	0.000398	0.00161	CcSEcCtD
Erlotinib—Erythema—Dexamethasone—ankylosing spondylitis	0.000398	0.00161	CcSEcCtD
Erlotinib—Syncope—Triamcinolone—ankylosing spondylitis	0.000393	0.00159	CcSEcCtD
Erlotinib—Syncope—Methylprednisolone—ankylosing spondylitis	0.000392	0.00159	CcSEcCtD
Erlotinib—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000391	0.00158	CcSEcCtD
Erlotinib—Oedema—Prednisolone—ankylosing spondylitis	0.000389	0.00157	CcSEcCtD
Erlotinib—Neutropenia—Methotrexate—ankylosing spondylitis	0.000388	0.00157	CcSEcCtD
Erlotinib—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000385	0.00156	CcSEcCtD
Erlotinib—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000384	0.00156	CcSEcCtD
Erlotinib—Shock—Prednisolone—ankylosing spondylitis	0.000383	0.00155	CcSEcCtD
Erlotinib—Cough—Triamcinolone—ankylosing spondylitis	0.000382	0.00155	CcSEcCtD
Erlotinib—Myalgia—Triamcinolone—ankylosing spondylitis	0.000373	0.00151	CcSEcCtD
Erlotinib—Pneumonia—Methotrexate—ankylosing spondylitis	0.000372	0.00151	CcSEcCtD
Erlotinib—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000372	0.00151	CcSEcCtD
Erlotinib—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000372	0.00151	CcSEcCtD
Erlotinib—Eye disorder—Prednisone—ankylosing spondylitis	0.000372	0.0015	CcSEcCtD
Erlotinib—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000371	0.0015	CcSEcCtD
Erlotinib—Infestation—Methotrexate—ankylosing spondylitis	0.00037	0.0015	CcSEcCtD
Erlotinib—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00037	0.0015	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00037	0.0015	CcSEcCtD
Erlotinib—Depression—Methotrexate—ankylosing spondylitis	0.000369	0.00149	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000367	0.00149	CcSEcCtD
Erlotinib—Renal failure—Methotrexate—ankylosing spondylitis	0.000364	0.00147	CcSEcCtD
Erlotinib—Stomatitis—Methotrexate—ankylosing spondylitis	0.000361	0.00146	CcSEcCtD
Erlotinib—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00036	0.00146	CcSEcCtD
Erlotinib—Oedema—Triamcinolone—ankylosing spondylitis	0.000358	0.00145	CcSEcCtD
Erlotinib—Syncope—Betamethasone—ankylosing spondylitis	0.000357	0.00144	CcSEcCtD
Erlotinib—Syncope—Dexamethasone—ankylosing spondylitis	0.000357	0.00144	CcSEcCtD
Erlotinib—Arrhythmia—Prednisone—ankylosing spondylitis	0.000355	0.00144	CcSEcCtD
Erlotinib—Infection—Triamcinolone—ankylosing spondylitis	0.000355	0.00144	CcSEcCtD
Erlotinib—Infection—Methylprednisolone—ankylosing spondylitis	0.000355	0.00144	CcSEcCtD
Erlotinib—Shock—Triamcinolone—ankylosing spondylitis	0.000352	0.00142	CcSEcCtD
Erlotinib—Insomnia—Prednisolone—ankylosing spondylitis	0.000352	0.00142	CcSEcCtD
Erlotinib—Alopecia—Prednisone—ankylosing spondylitis	0.000351	0.00142	CcSEcCtD
Erlotinib—Shock—Methylprednisolone—ankylosing spondylitis	0.000351	0.00142	CcSEcCtD
Erlotinib—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00035	0.00142	CcSEcCtD
Erlotinib—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00035	0.00142	CcSEcCtD
Erlotinib—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000349	0.00141	CcSEcCtD
Erlotinib—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000349	0.00141	CcSEcCtD
Erlotinib—Epistaxis—Methotrexate—ankylosing spondylitis	0.000349	0.00141	CcSEcCtD
Erlotinib—Mental disorder—Prednisone—ankylosing spondylitis	0.000348	0.00141	CcSEcCtD
Erlotinib—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000347	0.0014	CcSEcCtD
Erlotinib—Erythema—Prednisone—ankylosing spondylitis	0.000346	0.0014	CcSEcCtD
Erlotinib—Malnutrition—Prednisone—ankylosing spondylitis	0.000346	0.0014	CcSEcCtD
Erlotinib—Myalgia—Dexamethasone—ankylosing spondylitis	0.000339	0.00137	CcSEcCtD
Erlotinib—Myalgia—Betamethasone—ankylosing spondylitis	0.000339	0.00137	CcSEcCtD
Erlotinib—Anxiety—Dexamethasone—ankylosing spondylitis	0.000337	0.00137	CcSEcCtD
Erlotinib—Anxiety—Betamethasone—ankylosing spondylitis	0.000337	0.00137	CcSEcCtD
Erlotinib—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000334	0.00135	CcSEcCtD
Erlotinib—Pain—Prednisolone—ankylosing spondylitis	0.000333	0.00135	CcSEcCtD
Erlotinib—Hepatitis—Methotrexate—ankylosing spondylitis	0.000332	0.00135	CcSEcCtD
Erlotinib—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000332	0.00135	CcSEcCtD
Erlotinib—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000328	0.00133	CcSEcCtD
Erlotinib—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000326	0.00132	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000326	0.00132	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000325	0.00132	CcSEcCtD
Erlotinib—Oedema—Betamethasone—ankylosing spondylitis	0.000325	0.00131	CcSEcCtD
Erlotinib—Oedema—Dexamethasone—ankylosing spondylitis	0.000325	0.00131	CcSEcCtD
Erlotinib—Insomnia—Triamcinolone—ankylosing spondylitis	0.000323	0.00131	CcSEcCtD
Erlotinib—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000323	0.00131	CcSEcCtD
Erlotinib—Infection—Dexamethasone—ankylosing spondylitis	0.000322	0.00131	CcSEcCtD
Erlotinib—Infection—Betamethasone—ankylosing spondylitis	0.000322	0.00131	CcSEcCtD
Erlotinib—Shock—Betamethasone—ankylosing spondylitis	0.000319	0.00129	CcSEcCtD
Erlotinib—Shock—Dexamethasone—ankylosing spondylitis	0.000319	0.00129	CcSEcCtD
Erlotinib—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000319	0.00129	CcSEcCtD
Erlotinib—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000318	0.00129	CcSEcCtD
Erlotinib—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000318	0.00129	CcSEcCtD
Erlotinib—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000318	0.00129	CcSEcCtD
Erlotinib—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000318	0.00129	CcSEcCtD
Erlotinib—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000315	0.00127	CcSEcCtD
Erlotinib—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000314	0.00127	CcSEcCtD
Erlotinib—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000314	0.00127	CcSEcCtD
Erlotinib—Eye disorder—Methotrexate—ankylosing spondylitis	0.000311	0.00126	CcSEcCtD
Erlotinib—Syncope—Prednisone—ankylosing spondylitis	0.000311	0.00126	CcSEcCtD
Erlotinib—Anorexia—Betamethasone—ankylosing spondylitis	0.000309	0.00125	CcSEcCtD
Erlotinib—Anorexia—Dexamethasone—ankylosing spondylitis	0.000309	0.00125	CcSEcCtD
Erlotinib—Fatigue—Triamcinolone—ankylosing spondylitis	0.000308	0.00125	CcSEcCtD
Erlotinib—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000308	0.00125	CcSEcCtD
Erlotinib—Pain—Triamcinolone—ankylosing spondylitis	0.000306	0.00124	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000304	0.00123	CcSEcCtD
Erlotinib—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.0003	0.00121	CcSEcCtD
Erlotinib—Chills—Methotrexate—ankylosing spondylitis	0.000298	0.00121	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000296	0.0012	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000296	0.0012	CcSEcCtD
Erlotinib—Myalgia—Prednisone—ankylosing spondylitis	0.000295	0.00119	CcSEcCtD
Erlotinib—Arthralgia—Prednisone—ankylosing spondylitis	0.000295	0.00119	CcSEcCtD
Erlotinib—Anxiety—Prednisone—ankylosing spondylitis	0.000294	0.00119	CcSEcCtD
Erlotinib—Alopecia—Methotrexate—ankylosing spondylitis	0.000294	0.00119	CcSEcCtD
Erlotinib—Insomnia—Dexamethasone—ankylosing spondylitis	0.000294	0.00119	CcSEcCtD
Erlotinib—Insomnia—Betamethasone—ankylosing spondylitis	0.000294	0.00119	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000293	0.00119	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000292	0.00118	CcSEcCtD
Erlotinib—Mental disorder—Methotrexate—ankylosing spondylitis	0.000291	0.00118	CcSEcCtD
Erlotinib—Erythema—Methotrexate—ankylosing spondylitis	0.000289	0.00117	CcSEcCtD
Erlotinib—Malnutrition—Methotrexate—ankylosing spondylitis	0.000289	0.00117	CcSEcCtD
Erlotinib—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000286	0.00116	CcSEcCtD
Erlotinib—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000286	0.00116	CcSEcCtD
Erlotinib—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000283	0.00114	CcSEcCtD
Erlotinib—Oedema—Prednisone—ankylosing spondylitis	0.000283	0.00114	CcSEcCtD
Erlotinib—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000282	0.00114	CcSEcCtD
Erlotinib—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000282	0.00114	CcSEcCtD
Erlotinib—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000282	0.00114	CcSEcCtD
Erlotinib—Infection—Prednisone—ankylosing spondylitis	0.000281	0.00114	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00028	0.00113	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00028	0.00113	CcSEcCtD
Erlotinib—Back pain—Methotrexate—ankylosing spondylitis	0.00028	0.00113	CcSEcCtD
Erlotinib—Fatigue—Dexamethasone—ankylosing spondylitis	0.00028	0.00113	CcSEcCtD
Erlotinib—Fatigue—Betamethasone—ankylosing spondylitis	0.00028	0.00113	CcSEcCtD
Erlotinib—Shock—Prednisone—ankylosing spondylitis	0.000278	0.00113	CcSEcCtD
Erlotinib—Pain—Dexamethasone—ankylosing spondylitis	0.000277	0.00112	CcSEcCtD
Erlotinib—Pain—Betamethasone—ankylosing spondylitis	0.000277	0.00112	CcSEcCtD
Erlotinib—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000277	0.00112	CcSEcCtD
Erlotinib—Skin disorder—Prednisone—ankylosing spondylitis	0.000274	0.00111	CcSEcCtD
Erlotinib—Anorexia—Prednisone—ankylosing spondylitis	0.000269	0.00109	CcSEcCtD
Erlotinib—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000265	0.00107	CcSEcCtD
Erlotinib—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000265	0.00107	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000257	0.00104	CcSEcCtD
Erlotinib—Dizziness—Prednisolone—ankylosing spondylitis	0.000257	0.00104	CcSEcCtD
Erlotinib—Asthenia—Triamcinolone—ankylosing spondylitis	0.000257	0.00104	CcSEcCtD
Erlotinib—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000257	0.00104	CcSEcCtD
Erlotinib—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000257	0.00104	CcSEcCtD
Erlotinib—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000257	0.00104	CcSEcCtD
Erlotinib—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000257	0.00104	CcSEcCtD
Erlotinib—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000256	0.00104	CcSEcCtD
Erlotinib—Insomnia—Prednisone—ankylosing spondylitis	0.000256	0.00103	CcSEcCtD
Erlotinib—Pruritus—Triamcinolone—ankylosing spondylitis	0.000253	0.00102	CcSEcCtD
Erlotinib—Cough—Methotrexate—ankylosing spondylitis	0.000253	0.00102	CcSEcCtD
Erlotinib—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000252	0.00102	CcSEcCtD
Erlotinib—Dyspepsia—Prednisone—ankylosing spondylitis	0.000249	0.00101	CcSEcCtD
Erlotinib—Myalgia—Methotrexate—ankylosing spondylitis	0.000246	0.000997	CcSEcCtD
Erlotinib—Chest pain—Methotrexate—ankylosing spondylitis	0.000246	0.000997	CcSEcCtD
Erlotinib—Arthralgia—Methotrexate—ankylosing spondylitis	0.000246	0.000997	CcSEcCtD
Erlotinib—Decreased appetite—Prednisone—ankylosing spondylitis	0.000246	0.000994	CcSEcCtD
Erlotinib—Rash—Prednisolone—ankylosing spondylitis	0.000245	0.000993	CcSEcCtD
Erlotinib—Dermatitis—Prednisolone—ankylosing spondylitis	0.000245	0.000992	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000245	0.00099	CcSEcCtD
Erlotinib—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000244	0.000988	CcSEcCtD
Erlotinib—Fatigue—Prednisone—ankylosing spondylitis	0.000244	0.000986	CcSEcCtD
Erlotinib—Headache—Prednisolone—ankylosing spondylitis	0.000244	0.000986	CcSEcCtD
Erlotinib—Constipation—Prednisone—ankylosing spondylitis	0.000242	0.000978	CcSEcCtD
Erlotinib—Dizziness—Triamcinolone—ankylosing spondylitis	0.000236	0.000957	CcSEcCtD
Erlotinib—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000236	0.000955	CcSEcCtD
Erlotinib—Infection—Methotrexate—ankylosing spondylitis	0.000235	0.00095	CcSEcCtD
Erlotinib—Asthenia—Dexamethasone—ankylosing spondylitis	0.000233	0.000943	CcSEcCtD
Erlotinib—Asthenia—Betamethasone—ankylosing spondylitis	0.000233	0.000943	CcSEcCtD
Erlotinib—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000232	0.000938	CcSEcCtD
Erlotinib—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000231	0.000936	CcSEcCtD
Erlotinib—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000231	0.000935	CcSEcCtD
Erlotinib—Nausea—Prednisolone—ankylosing spondylitis	0.000231	0.000935	CcSEcCtD
Erlotinib—Pruritus—Betamethasone—ankylosing spondylitis	0.00023	0.000929	CcSEcCtD
Erlotinib—Pruritus—Dexamethasone—ankylosing spondylitis	0.00023	0.000929	CcSEcCtD
Erlotinib—Skin disorder—Methotrexate—ankylosing spondylitis	0.000229	0.000929	CcSEcCtD
Erlotinib—Vomiting—Triamcinolone—ankylosing spondylitis	0.000227	0.000921	CcSEcCtD
Erlotinib—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000227	0.000918	CcSEcCtD
Erlotinib—Rash—Triamcinolone—ankylosing spondylitis	0.000225	0.000913	CcSEcCtD
Erlotinib—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000225	0.000912	CcSEcCtD
Erlotinib—Anorexia—Methotrexate—ankylosing spondylitis	0.000225	0.000911	CcSEcCtD
Erlotinib—Rash—Methylprednisolone—ankylosing spondylitis	0.000225	0.000911	CcSEcCtD
Erlotinib—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000225	0.00091	CcSEcCtD
Erlotinib—Headache—Triamcinolone—ankylosing spondylitis	0.000224	0.000907	CcSEcCtD
Erlotinib—Headache—Methylprednisolone—ankylosing spondylitis	0.000224	0.000905	CcSEcCtD
Erlotinib—Abdominal pain—Prednisone—ankylosing spondylitis	0.000223	0.000904	CcSEcCtD
Erlotinib—Body temperature increased—Prednisone—ankylosing spondylitis	0.000223	0.000904	CcSEcCtD
Erlotinib—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000222	0.000899	CcSEcCtD
Erlotinib—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000222	0.000899	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000215	0.000871	CcSEcCtD
Erlotinib—Dizziness—Betamethasone—ankylosing spondylitis	0.000215	0.000869	CcSEcCtD
Erlotinib—Dizziness—Dexamethasone—ankylosing spondylitis	0.000215	0.000869	CcSEcCtD
Erlotinib—Insomnia—Methotrexate—ankylosing spondylitis	0.000214	0.000865	CcSEcCtD
Erlotinib—Nausea—Triamcinolone—ankylosing spondylitis	0.000212	0.00086	CcSEcCtD
Erlotinib—Nausea—Methylprednisolone—ankylosing spondylitis	0.000212	0.000858	CcSEcCtD
Erlotinib—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000211	0.000852	CcSEcCtD
Erlotinib—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000208	0.000842	CcSEcCtD
Erlotinib—Vomiting—Dexamethasone—ankylosing spondylitis	0.000206	0.000835	CcSEcCtD
Erlotinib—Vomiting—Betamethasone—ankylosing spondylitis	0.000206	0.000835	CcSEcCtD
Erlotinib—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000205	0.000831	CcSEcCtD
Erlotinib—Rash—Betamethasone—ankylosing spondylitis	0.000205	0.000828	CcSEcCtD
Erlotinib—Rash—Dexamethasone—ankylosing spondylitis	0.000205	0.000828	CcSEcCtD
Erlotinib—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000204	0.000828	CcSEcCtD
Erlotinib—Dermatitis—Betamethasone—ankylosing spondylitis	0.000204	0.000828	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000204	0.000825	CcSEcCtD
Erlotinib—Fatigue—Methotrexate—ankylosing spondylitis	0.000204	0.000824	CcSEcCtD
Erlotinib—Headache—Dexamethasone—ankylosing spondylitis	0.000203	0.000823	CcSEcCtD
Erlotinib—Headache—Betamethasone—ankylosing spondylitis	0.000203	0.000823	CcSEcCtD
Erlotinib—Asthenia—Prednisone—ankylosing spondylitis	0.000203	0.000821	CcSEcCtD
Erlotinib—Pain—Methotrexate—ankylosing spondylitis	0.000202	0.000818	CcSEcCtD
Erlotinib—Pruritus—Prednisone—ankylosing spondylitis	0.0002	0.000809	CcSEcCtD
Erlotinib—Diarrhoea—Prednisone—ankylosing spondylitis	0.000193	0.000783	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000193	0.000782	CcSEcCtD
Erlotinib—Nausea—Dexamethasone—ankylosing spondylitis	0.000193	0.00078	CcSEcCtD
Erlotinib—Nausea—Betamethasone—ankylosing spondylitis	0.000193	0.00078	CcSEcCtD
Erlotinib—Dizziness—Prednisone—ankylosing spondylitis	0.000187	0.000757	CcSEcCtD
Erlotinib—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000187	0.000756	CcSEcCtD
Erlotinib—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000187	0.000756	CcSEcCtD
Erlotinib—Vomiting—Prednisone—ankylosing spondylitis	0.00018	0.000727	CcSEcCtD
Erlotinib—Rash—Prednisone—ankylosing spondylitis	0.000178	0.000721	CcSEcCtD
Erlotinib—Dermatitis—Prednisone—ankylosing spondylitis	0.000178	0.000721	CcSEcCtD
Erlotinib—Headache—Prednisone—ankylosing spondylitis	0.000177	0.000717	CcSEcCtD
Erlotinib—Asthenia—Methotrexate—ankylosing spondylitis	0.000169	0.000686	CcSEcCtD
Erlotinib—Nausea—Prednisone—ankylosing spondylitis	0.000168	0.00068	CcSEcCtD
Erlotinib—Pruritus—Methotrexate—ankylosing spondylitis	0.000167	0.000676	CcSEcCtD
Erlotinib—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000162	0.000654	CcSEcCtD
Erlotinib—Dizziness—Methotrexate—ankylosing spondylitis	0.000156	0.000632	CcSEcCtD
Erlotinib—Vomiting—Methotrexate—ankylosing spondylitis	0.00015	0.000608	CcSEcCtD
Erlotinib—Rash—Methotrexate—ankylosing spondylitis	0.000149	0.000603	CcSEcCtD
Erlotinib—Dermatitis—Methotrexate—ankylosing spondylitis	0.000149	0.000602	CcSEcCtD
Erlotinib—Headache—Methotrexate—ankylosing spondylitis	0.000148	0.000599	CcSEcCtD
Erlotinib—Nausea—Methotrexate—ankylosing spondylitis	0.00014	0.000568	CcSEcCtD
